SK3272001A3 - A new composition - Google Patents
A new composition Download PDFInfo
- Publication number
- SK3272001A3 SK3272001A3 SK327-2001A SK3272001A SK3272001A3 SK 3272001 A3 SK3272001 A3 SK 3272001A3 SK 3272001 A SK3272001 A SK 3272001A SK 3272001 A3 SK3272001 A3 SK 3272001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- component
- treatment
- composition according
- composition
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803157A SE9803157D0 (sv) | 1998-09-16 | 1998-09-16 | A new composition |
| PCT/SE1999/001598 WO2000015219A1 (en) | 1998-09-16 | 1999-09-13 | A new composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK3272001A3 true SK3272001A3 (en) | 2001-09-11 |
Family
ID=20412628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK327-2001A SK3272001A3 (en) | 1998-09-16 | 1999-09-13 | A new composition |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1121119A1 (hu) |
| JP (1) | JP2002524509A (hu) |
| KR (1) | KR20010099648A (hu) |
| CN (1) | CN1317963A (hu) |
| AR (1) | AR023657A1 (hu) |
| AU (1) | AU6378199A (hu) |
| BR (1) | BR9913765A (hu) |
| CA (1) | CA2342585A1 (hu) |
| CZ (1) | CZ2001962A3 (hu) |
| EE (1) | EE200100156A (hu) |
| HU (1) | HUP0103569A3 (hu) |
| ID (1) | ID28359A (hu) |
| IL (1) | IL141520A0 (hu) |
| IS (1) | IS5877A (hu) |
| NO (1) | NO20011313L (hu) |
| PL (1) | PL346769A1 (hu) |
| SE (1) | SE9803157D0 (hu) |
| SK (1) | SK3272001A3 (hu) |
| TR (1) | TR200100769T2 (hu) |
| WO (1) | WO2000015219A1 (hu) |
| ZA (1) | ZA200101951B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR021155A1 (es) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
| EP1358177B1 (en) | 2000-10-13 | 2006-08-02 | NeuroSearch A/S | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| WO2006038217A1 (en) * | 2004-10-05 | 2006-04-13 | Strides Acrolab Limited | An improved drug delivery system of citalopram hydrobromide and process for producing the same |
| EP1901714A2 (en) | 2005-05-20 | 2008-03-26 | Aurobindo Pharma Limited | Pharmaceutical dosage forms comprising escitalopram in form of granules |
| TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1998
- 1998-09-16 SE SE9803157A patent/SE9803157D0/xx unknown
-
1999
- 1999-09-13 WO PCT/SE1999/001598 patent/WO2000015219A1/en not_active Application Discontinuation
- 1999-09-13 IL IL14152099A patent/IL141520A0/xx unknown
- 1999-09-13 TR TR2001/00769T patent/TR200100769T2/xx unknown
- 1999-09-13 HU HU0103569A patent/HUP0103569A3/hu unknown
- 1999-09-13 CZ CZ2001962A patent/CZ2001962A3/cs unknown
- 1999-09-13 BR BR9913765-8A patent/BR9913765A/pt not_active Application Discontinuation
- 1999-09-13 PL PL99346769A patent/PL346769A1/xx unknown
- 1999-09-13 EP EP99951320A patent/EP1121119A1/en not_active Withdrawn
- 1999-09-13 AU AU63781/99A patent/AU6378199A/en not_active Abandoned
- 1999-09-13 CA CA002342585A patent/CA2342585A1/en not_active Abandoned
- 1999-09-13 SK SK327-2001A patent/SK3272001A3/sk unknown
- 1999-09-13 JP JP2000569803A patent/JP2002524509A/ja active Pending
- 1999-09-13 ID IDW20010580A patent/ID28359A/id unknown
- 1999-09-13 CN CN99811007A patent/CN1317963A/zh active Pending
- 1999-09-13 EE EEP200100156A patent/EE200100156A/xx unknown
- 1999-09-13 KR KR1020017003338A patent/KR20010099648A/ko not_active Application Discontinuation
- 1999-09-15 AR ARP990104627A patent/AR023657A1/es unknown
-
2001
- 2001-03-05 IS IS5877A patent/IS5877A/is unknown
- 2001-03-08 ZA ZA200101951A patent/ZA200101951B/xx unknown
- 2001-03-15 NO NO20011313A patent/NO20011313L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010099648A (ko) | 2001-11-09 |
| ID28359A (id) | 2001-05-17 |
| CA2342585A1 (en) | 2000-03-23 |
| HUP0103569A3 (en) | 2002-03-28 |
| NO20011313D0 (no) | 2001-03-15 |
| ZA200101951B (en) | 2002-06-10 |
| IL141520A0 (en) | 2002-03-10 |
| SE9803157D0 (sv) | 1998-09-16 |
| CZ2001962A3 (cs) | 2001-08-15 |
| EP1121119A1 (en) | 2001-08-08 |
| BR9913765A (pt) | 2001-06-05 |
| HUP0103569A2 (hu) | 2002-02-28 |
| AR023657A1 (es) | 2002-09-04 |
| PL346769A1 (en) | 2002-02-25 |
| NO20011313L (no) | 2001-05-16 |
| IS5877A (is) | 2001-03-05 |
| AU6378199A (en) | 2000-04-03 |
| JP2002524509A (ja) | 2002-08-06 |
| WO2000015219A1 (en) | 2000-03-23 |
| CN1317963A (zh) | 2001-10-17 |
| EE200100156A (et) | 2002-08-15 |
| TR200100769T2 (tr) | 2001-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6184218B1 (en) | Composition and methods employing it for the treatment of 5-HT-mediated disorders | |
| CA2400797A1 (en) | Therapeutic agents | |
| MX2007013064A (es) | Metodo para modular la funcion de la vejiga. | |
| JP2003529563A (ja) | ビュープロピオン代謝産物並びにその合成および使用方法 | |
| EA003142B1 (ru) | Лекарственное средство, обладающее антидепрессивным действием, его применение и способ лечения | |
| IL135825A (en) | Production of a medicinal product that includes myrtzepine for the treatment of sleep apnea | |
| AU2483499A (en) | Pharmaceutical uses of optically pure (+)-bupropion | |
| US6472423B1 (en) | Pharmaceutical composition | |
| SK3272001A3 (en) | A new composition | |
| AU6378299A (en) | A new composition | |
| SK3262001A3 (en) | A new composition | |
| CA2342223A1 (en) | A new composition | |
| RU2238084C2 (ru) | Композиции, содержащие ингибиторы обратного захвата допамина, и способы их применения | |
| MXPA01002543A (en) | A new composition | |
| AU2003220743B2 (en) | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders | |
| AU1570200A (en) | Use of a 5HT2a and 5HT2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways | |
| MXPA01002370A (en) | A new composition | |
| MXPA00004609A (en) | Use of mirtazapine for treating sleep apneas |